1,513 Followers on Owler

VBI

Read more
Jeff Baxter's photo - President & CEO of VBI

President & CEO

Jeff Baxter

CEO Approval Rating

89/100

Founded:

2001

Status:

PublicAcquisition Pending from SciVac Therapeutics, Inc.NASDAQVBIV

VBI Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$ < 1M

VBI's revenue is the ranked 16th among it's top 10 competitors. The top 10 competitors average 226.1M. Over the last three quarters, VBI's revenue has decreased by 97%. Specifically, in Q4 2015's revenue was $ < 1M; in Q3 2015, it was $ < 1M; in Q2 2015, it was $ < 1M.

VBI News

VBI Press Releases

VBI Videos

Social Media

VBI Headquarters

222 Third Street Suite 2241

Cambridge, Massachusetts02142

617-830-3031

Driving Directions »

VBI Summary

ABOUT

Overview

VBI Vaccines is a pharmaceutical company that researches and develops novel vaccines for the treatment of cancer and infectious diseases. VBI was founded in 2001. VBI's headquarters is located in Cambridge, Massachusetts, USA 02142. It has raised 194....

CEO

VBI's President & CEO, Jeff Baxter, currently has an approval rating of 89%. VBI's primary competitors are Dynavax, Hookipa Pharma & BioNTech.

Acquisitions

There have been no acquisitions found related to VBI

Investments

Recent investment data cannot be found related to VBI

Frequently Asked Questions about VBI

  1. When was VBI founded?

    VBI was founded in 2001
  2. Who is VBI's CEO?

    VBI's CEO is Jeff Baxter
  3. How much revenue does VBI generate?

    VBI generates $ < 1M in revenue
  4. How much funding does VBI have?

    VBI has historically raised $194.4M in funding
  1. Where is VBI's headquarters?

    VBI's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does VBI have?

    VBI has 22 employees
  3. What sector does VBI operate in?

    VBI is in Pharmaceuticals
  4. Who are VBI's competitors?

    VBI's top competitors are Dynavax, Hookipa Pharma, BioNTech

Trending Companies